Publication of Prospectus
· a perpetual non-call 5.25 year capital security at
· a perpetual non-call 8.0 year capital security at
The Securities will be accounted as equity in accordance with IFRS standards. The Securities will receive an equity credit of 50% from Moody's, Standard & Poor's and Fitch.
The net proceeds from the issuance will be used for general corporate purposes, including (i) the repurchase of the Company's outstanding Perpetual Subordinated NC 2026 Securities via a tender offer that was launched on
The first call dates of the Securities are (i) any business day following
The settlement is expected to take place on
To view the Prospectus which has been approved by the Financial Conduct Authority, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/1506F_1-2025-10-28.pdf
The Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Enquiries:
Media Centre
press_office@bat.com | @BATplc
Investor Relations
Globe House
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
This announcement does not constitute or form part of an offer or invitation to sell or issue, or any solicitation of an offer to buy or subscribe for, any securities in
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the